Characterization of In Vivo Retinal Lesions of Diabetic Retinopathy Using Adaptive Optics Scanning Laser Ophthalmoscopy

Figure 4

Response of proliferative diabetic retinopathy to anti-VEGF therapy on AOSLO. (a) Fundus photograph of neovascularization at the optic disc (NVD). (b) MSL AOSLO image of the area highlighted by the white box in (a). (c, d) Same NVD 4 weeks after administration of intravitreal ranibizumab. The NVD can no longer be identified in the infrared image; however, AOSLO imaging reveals the persistence of an involuted neovascular formation.

(a)

(b)

(c)

(d)